Clinical Trials Logo

Filter by:
NCT ID: NCT04812951 Completed - Clinical trials for Ocular Surface Disease

Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery

CSA2020
Start date: February 17, 2021
Phase: Early Phase 1
Study type: Interventional

Use of Cyclosporine 0.1% Eye Drops as Prophylactic Treatment in cataract Surgery

NCT ID: NCT04812782 Completed - Type 1 Diabetes Clinical Trials

Dietary Fat and Endothelial Function in Type 1 Diabetes

Start date: February 12, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of the add-on of extra vergin olive oil or butter to a high glycemic index meal on endothelial function in subjects with type 1 Diabetes and healthy subjects.

NCT ID: NCT04811898 Completed - Clinical trials for Advanced Solid Tumor

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment

LNA-i-miR221
Start date: January 14, 2019
Phase: Phase 1
Study type: Interventional

The LNA-i-miR-221 Phase I trial has been designed as a monocentric open label dose escalation study which received written approval by the Competent Authority and independent Ethics Committee (IEC). LNA-i-miR-221 will be investigated for safety and tolerability in patients, men and women age ≥18 yrs, affected by Refractory-MM and advanced solid tumors.

NCT ID: NCT04811781 Completed - Solid Tumor, Adult Clinical Trials

Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study

Start date: June 4, 2020
Phase:
Study type: Observational

The study aims to retrospectively collect epidemiological and clinical data in patients with solid tumors and SARS Covid2 infections belonging to oncology centers within the Veneto Oncology Network

NCT ID: NCT04811365 Completed - Clinical trials for Systemic Mast Cell Activation

(PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation

Start date: June 29, 2021
Phase:
Study type: Observational

This is a multi-center screening study with the primary objective to determine the prevalence of KIT D816V mutation in peripheral blood in patients with evidence of systemic mast cell activation (MCA).

NCT ID: NCT04810221 Completed - Clinical trials for Laboratory Testing on Healthy Volunteers to Verify SpO2 and Heart Rate (HR) Accuracy of BrOxy M

Postmarket Clinical Follow-up Study to Confirm the Performance of the Wearable Pulse-Oximeter BrOxy M (SOMBRERO)

SOMBRERO
Start date: March 24, 2021
Phase: N/A
Study type: Interventional

This study is a post market clinical follow up study performed to confirm the performance of BrOxy M pulse oximeter in comparison with a reference, CE marked, pulse oximeter equipment in a controlled desaturation study over a range between 80% and 100% peripheral oxygen saturation (SpO2). The study will be performed on a group of healthy volunteers in a controlled clinical setting.

NCT ID: NCT04810182 Completed - Clinical trials for Glioblastoma Multiforme

Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS

Start date: September 10, 2020
Phase:
Study type: Observational

This study aims to analyze the role the of Regorafenib in prolonging the Overall Survival of glioblastoma multiforme patients who progressed after surgery and a first-line chemo-radiotherapy treatment in the setting of "real world life".

NCT ID: NCT04809831 Completed - Clinical trials for Periodontal Diseases

The Use of Biorepair Peribioma Toothpaste and Mousse for Home Oral Care in Patients Undergoing Periodontal Therapy

Start date: March 22, 2021
Phase: N/A
Study type: Interventional

This is a split-mouth randomized clinical trial in which a new domiciliary oral care protocol with Biorepair Peribioma Toothpaste and Mousse is evaluated in periodontal patients.

NCT ID: NCT04809090 Completed - Work Related Stress Clinical Trials

CO-ADAPT: Adaptive Environments and Conversational Agent Based Approaches for Healthy Ageing and Work Ability

Start date: March 9, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to identify effective methodologies to help people improve their ability to adapt to psychological stress.

NCT ID: NCT04808557 Completed - Dental Caries Clinical Trials

SEM Evaluation of the Quantity of microRepair® on Resin Composite Surfaces: an in Vivo Randomized Clinical Trial.

Start date: March 24, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the quantity of Biorepair Total Protection toothpaste on composite surfaces inside oral cavity. Three orthodontic lingual buttons are bonded on the vestibular surfaces of upper right premolars (1.4 and 1.5) and upper right first molars (1.6) of volunteers. A composite resine is applied upon them. Then, after 7 days, 1.4 button will be debonded; after 15 days, 1.5 button are debonded; in the end, after 30 days the last button (1.6) is debonded. The buttons will be stored in sterile environment and then sent to laboratory for SEM evaluation.